These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 20363332

  • 1. Recombinant production of bioactive human TNF-alpha by SUMO-fusion system--high yields from shake-flask culture.
    Hoffmann A, Müller MQ, Gloser M, Sinz A, Rudolph R, Pfeifer S.
    Protein Expr Purif; 2010 Aug; 72(2):238-43. PubMed ID: 20363332
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Expression, purification and refolding of streptavidin-tagged human tumor necrosis factor-alpha fusion protein].
    Xu CX, Hu ZM, Li JL, Gao JM.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):412-5. PubMed ID: 19304513
    [Abstract] [Full Text] [Related]

  • 4. Purification and characterization of human and mouse recombinant alpha-fetoproteins expressed in Escherichia coli.
    Boismenu R, Semeniuk D, Murgita RA.
    Protein Expr Purif; 1997 Jun; 10(1):10-26. PubMed ID: 9179285
    [Abstract] [Full Text] [Related]

  • 5. Production and characterization of recombinant human and murine TNF.
    Curnis F, Corti A.
    Methods Mol Med; 2004 Jun; 98():9-22. PubMed ID: 15064429
    [Abstract] [Full Text] [Related]

  • 6. Expression and purification of human PYY(3-36) in Escherichia coli using a His-tagged small ubiquitin-like modifier fusion.
    Fazen CH, Kahkoska AR, Doyle RP.
    Protein Expr Purif; 2012 Sep; 85(1):51-9. PubMed ID: 22771863
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
    Scherf U, Benhar I, Webber KO, Pastan I, Brinkmann U.
    Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression and purification of an antitumor-analgesic peptide from the venom of Mesobuthus martensii Karsch by small ubiquitin-related modifier fusion in Escherichia coli.
    Cao P, Yu J, Lu W, Cai X, Wang Z, Gu Z, Zhang J, Ye T, Wang M.
    Biotechnol Prog; 2010 Sep; 26(5):1240-4. PubMed ID: 20945481
    [Abstract] [Full Text] [Related]

  • 10. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
    Urieto JO, Liu T, Black JH, Cohen KA, Hall PD, Willingham MC, Pennell LK, Hogge DE, Kreitman RJ, Frankel AE.
    Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
    [Abstract] [Full Text] [Related]

  • 11. Optimization of BLyS production and purification from Escherichia coli.
    Laird MW, Sampey GC, Johnson K, Zukauskas D, Pierre J, Hong JS, Cooksey BA, Li Y, Galperina O, Karwoski JD, Burke RN.
    Protein Expr Purif; 2005 Feb; 39(2):237-46. PubMed ID: 15642475
    [Abstract] [Full Text] [Related]

  • 12. Influence of the protein oligomericity on final yield after affinity tag removal in purification of recombinant proteins.
    Kenig M, Peternel S, Gaberc-Porekar V, Menart V.
    J Chromatogr A; 2006 Jan 06; 1101(1-2):293-306. PubMed ID: 16256128
    [Abstract] [Full Text] [Related]

  • 13. Expression, purification and characterization of aprotinin and a human analogue of aprotinin.
    Sun Z, Lu W, Jiang A, Chen J, Tang F, Liu JN.
    Protein Expr Purif; 2009 Jun 06; 65(2):238-43. PubMed ID: 19152836
    [Abstract] [Full Text] [Related]

  • 14. Production of recombinant peptides as fusions with SUMO.
    Satakarni M, Curtis R.
    Protein Expr Purif; 2011 Aug 06; 78(2):113-9. PubMed ID: 21586326
    [Abstract] [Full Text] [Related]

  • 15. Generation of tumour-necrosis-factor-alpha-specific affibody molecules capable of blocking receptor binding in vitro.
    Jonsson A, Wållberg H, Herne N, Ståhl S, Frejd FY.
    Biotechnol Appl Biochem; 2009 Aug 17; 54(2):93-103. PubMed ID: 19545237
    [Abstract] [Full Text] [Related]

  • 16. Expression and purification of soluble human APRIL in Escherichia coli using ELP-SUMO tag.
    Zhang J, Ma L, Zhang SQ.
    Protein Expr Purif; 2014 Mar 17; 95():177-81. PubMed ID: 24412409
    [Abstract] [Full Text] [Related]

  • 17. Preparation of recombinant murine tumor necrosis factor-alpha in Escherichia coli: a rapid method to remove tags from fusion proteins by thrombin-cleavage and ion-exchange chromatography.
    Tsukamoto H, Fukudome K, Kohara J, Nakatake H, Kimoto M.
    Protein Expr Purif; 2007 Nov 17; 56(1):138-44. PubMed ID: 17703948
    [Abstract] [Full Text] [Related]

  • 18. Expression and purification of the ligand-binding domain of peroxisome proliferator-activated receptor alpha (PPARalpha).
    Müller MQ, Roth C, Sträter N, Sinz A.
    Protein Expr Purif; 2008 Dec 17; 62(2):185-9. PubMed ID: 18755277
    [Abstract] [Full Text] [Related]

  • 19. High yield expression and single step purification of human thionein/metallothionein.
    Hong S, Toyama M, Maret W, Murooka Y.
    Protein Expr Purif; 2001 Feb 17; 21(1):243-50. PubMed ID: 11162412
    [Abstract] [Full Text] [Related]

  • 20. Monitoring cleavage of fusion proteins by matrix-assisted laser desorption ionization/mass spectrometry: recombinant HIV-1IIIB p26.
    Parker CE, Papac DI, Tomer KB.
    Anal Biochem; 1996 Jul 15; 239(1):25-34. PubMed ID: 8660621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.